Survey Study for Pain Management, Wound Care, Scar Care or UDT
Survey of Patients Who Have Been Prescribed a Topical Compound for Pain Management, Wound Care or Scar Care or to Patients Who Have Been Requested to do a Urinary Drug Test (UDT) by Their Provider.
1 other identifier
observational
10,000
1 country
1
Brief Summary
This is a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider. The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 15, 2014
CompletedFirst Posted
Study publicly available on registry
July 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedJanuary 28, 2015
January 1, 2015
3.1 years
July 15, 2014
January 27, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Change in pain survey results from baseline at 30 days
Survey on pain management
baseline and 30 days
Change in pain survey results from baseline at 60 days
Survey on pain management
baseline and 60 days
Change in pain survey results from baseline at 90 days
Survey on pain management
baseline and 90 days
Change in scar care survey results from baseline at 30 days
Survey on scar care
baseline and 30 days
Change in scar care survey results from baseline at 60 days
Survey on scar care
baseline and 60 days
Change in scar care survey results from baseline at 90 days
Survey on scar care
baseline and 90 days
Change in wound care survey results from baseline at 30 days
Survey on wound care
baseline and 30 days
Change in wound care survey results from baseline at 60 days
Survey on wound care
baseline and 60 days
Change in wound care survey results from baseline at 90 days
Survey on wound care
baseline and 90 days
Change in UDT survey results from baseline at 30 days
Survey on urinary drug testing
baseline and 30 days
Change in UDT survey results from baseline at 60 days
Survey on urinary drug testing
baseline and 60 days
Change in UDT survey results from baseline at 90 days
Survey on urinary drug testing
baseline and 90 days
Secondary Outcomes (12)
Change in pain survey results from 30 days at 60 days
30 days and 60 days
Change in pain survey results from 30 days at 90 days
30 days and 90 days
Change in pain survey results from 60 days at 90 days
60 days and 90 days
Length of hospital stay
at baseline
Change in scar care survey results from 30 days at 60 days
30 days and 60 days
- +7 more secondary outcomes
Study Arms (4)
Pain management
patients undergoing transdermal treatment for pain
Scar care
patients undergoing transdermal treatment for scars
Wound care
patients undergoing transdermal treatment for wounds
UDT
patients receiving urinary drug tests
Eligibility Criteria
Patients who are given a prescription for topical compound for pain, scar care, or wound care, and agree to complete the surveys or Patients who are given a UDT and agree to complete the surveys. Patients will be recruited into the study if their providers prescribe a topical cream for pain, scar care or wound care or if the provider performs a UDT prior to treatment or surgery. The providers will follow their office procedure for UDT. If they perform a UDT and the patient agrees to participate in the survey study, they will have the patient complete the surveys.
You may qualify if:
- Prescribed a topical cream for pain, scar care, or wound OR Provider preforms urinary drug test
You may not qualify if:
- Subjects with legally authorized representatives
- Minors
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rahm Foundationlead
- Datum Research, LLCcollaborator
Study Sites (1)
Blueprint Pathways
Nashville, Tennessee, 37203, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2014
First Posted
July 21, 2014
Study Start
November 1, 2013
Primary Completion
December 1, 2016
Last Updated
January 28, 2015
Record last verified: 2015-01